Home/Filings/4/0001469709-12-000124
4//SEC Filing

SOBOL PHILIP A 4

Accession 0001469709-12-000124

CIK 0001408299other

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 5:58 PM ET

Size

10.6 KB

Accession

0001469709-12-000124

Insider Transaction Report

Form 4
Period: 2012-05-18
Transactions
  • Award

    Series A Preferred Stock

    2012-05-18$5.00/sh+5,000$25,0005,000 total(indirect: By Trust)
    Exercise: $0.50From: 2012-05-18Common Stock (50,000 underlying)
  • Award

    Convertible Promissory Note

    2012-05-18$25000.00/sh+1$25,0001 total
    Exercise: $5.00From: 2012-05-18Exp: 2012-12-31Series A Preferred Stock
  • Award

    Common Stock Purchase Warrant

    2012-05-18+150,000150,000 total(indirect: By Trust)
    Exercise: $0.55From: 2012-05-18Exp: 2017-05-17Common Stock (150,000 underlying)
Footnotes (3)
  • [F1]The conversion price is adjustable pursuant to certain anti-dilution provisions.
  • [F2]The preferred shares are convertible into common shares at any time,but under certain circumstances there could be a mandatory conversion, as for example after the annivesary of the effectiveness of a registration statement covering the common stock underlying the preferred shares or within 30 days of the closing of a private placement exceeding $5 million.
  • [F3]These warrants were issued as an incentive for making a loan. No valuation or pricing of the warrants has been done.

Issuer

Entia Biosciences, Inc.

CIK 0001408299

Entity typeother

Related Parties

1
  • filerCIK 0001426043

Filing Metadata

Form type
4
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 5:58 PM ET
Size
10.6 KB